Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AVN-944 (VX-944)(VX-944) is a selective, noncompetitive inhibitor of human IMPDH with Ki of 6-10 nM for IMPDH1/IMPDH2.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 12,500 | |||
5 mg | 在庫あり | ¥ 20,500 | |||
10 mg | 在庫あり | ¥ 32,000 | |||
25 mg | 在庫あり | ¥ 68,500 | |||
50 mg | 在庫あり | ¥ 110,000 | |||
100 mg | 在庫あり | ¥ 158,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 22,500 |
説明 | AVN-944 (VX-944)(VX-944) is a selective, noncompetitive inhibitor of human IMPDH with Ki of 6-10 nM for IMPDH1/IMPDH2. |
ターゲット&IC50 | IMPDH:6-10 nM(Ki) |
別名 | VX-944 |
分子量 | 477.51 |
分子式 | C25H27N5O5 |
CAS No. | 297730-17-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 55 mg/mL (115.18 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AVN-944 297730-17-7 Metabolism Dehydrogenase VX944 AVN944 multiple myeloma RPMI8226 Caspase VX 944 Apoptosis BMSCs IMPDH Arenavirus Bcl-2 Family U266 cells inhibit DNA/RNA Synthesis acute myeloid leukemia AML MM.1S oncolytic activity VX-944 Inhibitor AIF Endo G AVN 944 caspase-independent inhibitor